FDA EIR - Novartis Gene Therapies, Inc. - February 15, 2019

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This EIR record concerns Novartis Gene Therapies, Inc., with an inspection on February 15, 2019, covering other.

Company: Novartis Gene Therapies, Inc.
Inspection Date: February 15, 2019
Product Type: Other
People: Rebecca Clancy
Andrew Le (Regulatory Affairs Specialist)
Taryn Cozine
Allan Kaspar
Mark F. Binkley (Dr.)

ID · f5f81226-4da7-4cdc-91da-5e61e1786be0

Violation Codes4

FD&C Act 801(a)(3)FD&C Act 501(a)(2)(B)FD&C Act 501(c)FD&C Act 704

Full citation text and observation details available on the Dashboard.